（编辑 姚尧） 证券日报网讯 1月29日，华菱钢铁在互动平台回答投资者提问时表示，上市公司的股价表现受宏观环 境、市场情绪、投资者偏好等多种因素影响，应秉持客观、动态的视角予以综合评估。在市值表现方 面，公司2025年股价上涨37.58%，分别跑赢上证指数、申万普钢指数19.17、16.98个百分点。 ...

Core Viewpoint - Jiuzhou Pharmaceutical (603456) acknowledges that its stock performance is influenced by multiple factors, including market conditions and sector rotation, while actively communicating its core value to the capital market [1] Group 1 - The company has implemented a new round of share buybacks, cancellation of treasury shares, and mid-term dividends this year [1]